Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study.

Sivan GazitRoei ShlezingerGalit PerezRoni LotanAsaf PeretzAmir Ben-TovEsma HerzelHillel AlapiDani CohenKhitam MuhsenGabriel ChodickTal Patalon

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

Naturally acquired immunity confers stronger protection against infection and symptomatic disease caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 2-dose vaccine-indued immunity.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
high glucose
drug induced